Author: Liu, Xinsheng; Zhao, Donghong; Zhou, Peng; Zhang, Yongguang; Wang, Yonglu
Title: Evaluation of the Efficacy of a Recombinant Adenovirus Expressing the Spike Protein of Porcine Epidemic Diarrhea Virus in Pigs Document date: 2019_10_8
ID: 1lxd2457_38
Snippet: In conclusion, the present study showed that the PEDV S protein derived from emerging PEDV variants could be inserted into an adenovirus vector and successfully expressed in vitro. Further animal studies showed that rAd-PEDV-S could induce a high humoral immune response and confer partial protection for pigs against the highly virulent PEDV challenge......
Document: In conclusion, the present study showed that the PEDV S protein derived from emerging PEDV variants could be inserted into an adenovirus vector and successfully expressed in vitro. Further animal studies showed that rAd-PEDV-S could induce a high humoral immune response and confer partial protection for pigs against the highly virulent PEDV challenge.
Search related documents:
Co phrase search for related documents- adenovirus vector and highly virulent PEDV challenge: 1, 2
- adenovirus vector and humoral immune response: 1, 2, 3, 4
- adenovirus vector and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- adenovirus vector and partial protection: 1, 2, 3, 4
- adenovirus vector and PEDV challenge: 1, 2
- adenovirus vector and present study: 1, 2, 3, 4, 5, 6
- animal study and humoral immune response: 1
- animal study and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- animal study and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
- high humoral immune response and humoral immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- high humoral immune response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- high humoral immune response and present study: 1, 2, 3
- highly virulent PEDV challenge and humoral immune response: 1
- highly virulent PEDV challenge and immune response: 1, 2, 3
- highly virulent PEDV challenge and partial protection: 1, 2, 3
- highly virulent PEDV challenge and PEDV challenge: 1, 2, 3, 4, 5, 6, 7
- highly virulent PEDV challenge and PEDV variant: 1
- highly virulent PEDV challenge and present study: 1
- humoral immune response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79
Co phrase search for related documents, hyperlinks ordered by date